GlassScriptPhysician profile
Robert N Dangelo
NPI 1225487630
$9,787.24
in general payments reported to CMS, 2019-2025
6 companies · $1,688 in 2025
The $1,688 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $329 · 2023: $4,562 · 2024: $2,750 · 2025: $1,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,477 · Travel and Lodging: $3,783 · Education: $440 · Grant: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,477.38 |
| Travel and Lodging | $3,783.34 |
| Education | $439.67 |
| Grant | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,687.25 | 2021-2025 | Aveir, Ensite, Ensite Precision |
| Biotronik INC. | $2,172.60 | 2023-2024 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $2,098.86 | 2023-2024 | S-Icd System Magnet |
| Medtronic, INC. | $732.00 | 2022-2024 | Micra |
| Biosense Webster, INC. | $565.68 | 2024-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medical Device Business Services, INC. | $530.85 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dangelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.